Sonnet BioTherapeutics Holdings, Inc. (SONN)
NASDAQ: SONN · Real-Time Price · USD
1.120
-0.030 (-2.61%)
Jun 27, 2025, 4:00 PM - Market closed
SONN Market Cap
SONN has a market cap or net worth of $3.55 million as of June 27, 2025. Its market cap has decreased by -42.17% in one year.
Market Cap
3.55M
Enterprise Value
1.58M
1-Year Change
-42.17%
Ranking
Category
Stock Price
$1.12
Market Cap Chart
Since April 2, 2020, SONN's market cap has decreased from $58.10M to $3.55M, a decrease of -93.90%. That is a compound annual growth rate of -41.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2025 | 3.64M | -17.08% |
| Dec 31, 2024 | 4.39M | -17.79% |
| Dec 29, 2023 | 5.34M | -41.46% |
| Dec 30, 2022 | 9.12M | -63.34% |
| Dec 31, 2021 | 24.89M | -35.01% |
| Dec 31, 2020 | 38.30M | -34.08% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 711.28B |
| Johnson & Johnson | 366.40B |
| AbbVie | 327.47B |
| Novo Nordisk | 301.06B |
| UnitedHealth Group | 273.97B |
| Abbott Laboratories | 239.05B |
| Novartis AG | 231.01B |
| AstraZeneca | 216.45B |